Web20 mag 2009 · 4545 Background: Gastric cancer (GC) with peritoneal metastasis (PM) often complicates ascites or intestinal stenosis and the prognosis is still poor. Anti-cancer drugs generally can not be administered for such patients (pts) due to the risk of serious and prolonged adverse events. However, 5FU-based chemotherapy is reportedly relatively … Web18 dic 2024 · Background In this study, we tried to access the efficacy and safety of oxaliplatin plus S-1 with intraperitoneal paclitaxel (PTX) for the treatment of Chinese advanced gastric cancer with peritoneal metastases. Patients and methods Thirty patients diagnosed with advanced gastric cancer underwent laparoscopic exploration …
Modified FOLFOX6 as a first-line treatment for patients with …
Web14 nov 2024 · In general, when we treat AGC patients with inadequate oral intake due to massive ascites or peritoneal metastases, 5-fluorouracil (5-FU)/l-leucovorin (l-LV) is the most widely used based on the result of the JCOG0106 trial. 11 However, the treatment outcome of 5-FU/l-LV therapy is rather poor compared with the combination therapy of … Web1 nov 2010 · Request PDF On Nov 1, 2010, Yamaguchi Kensei and others published RANDOMIZED PHASE III STUDY OF 5-FU CI VS MTX+5-FU IN GASTRIC CANCER … kapral tire and auto
RANDOMIZED PHASE III STUDY OF 5-FU CI VS MTX+5-FU IN
Web23 nov 2024 · Massive ascites was defined as continuous ascites from the pelvic cavity to the upper abdomen. Improvement in oral intake was defined as no TPN for more than 7 … Webjcog0106：腹膜転移を有する進行胃がんに対する5-fu持続静注療法(5-fuci) vs mtx+5-fu時間差療法 (mf)による第iii相試験 作成：2012年8月20日 研究事務局：白尾国昭 (大分大学 … WebStudio randomizzato di fase III sull'infusione continua di 5-FU (5FUci) rispetto alla terapia sequenziale MTX+5-FU (MF) nel cancro gastrico con metastasi peritoneali (JCOG0106-MF, MF/5FU) law of flexibility